Reference : The 5-HT1A agonism potential of substituted-piperazine-ethyl-amide derivatives is conser...
Scientific journals : Article
Engineering, computing & technology : Computer science Human health sciences : Pharmacy, pharmacology & toxicology
http://hdl.handle.net/2268/99156
The 5-HT1A agonism potential of substituted-piperazine-ethyl-amide derivatives is conserved in the hexyl homologues: molecular modeling and pharmacological evaluation
English
Dilly, Sébastien[Université de Liège - ULg > Département de Pharmacie / GIGA-Neuroscience > Chimie Pharmaceutique / Pharmacologie > >]
Scuvée-Moreau, Jacqueline[Université de Liège - ULg > Département des sciences biomédicales et précliniques > Pharmacologie >]
Wouters, Johan[Université de Namur > Département de Chimie > > >]
Liégeois, Jean-François[Université de Liège - ULg > Département de pharmacie > Chimie pharmaceutique >]
[en] In a series of carboxamide and sulphonamide alkyl (ethyl to hexyl) piperazine analogues, although the size of the linker is very different, ethyl and hexyl derivatives possess a high affinity for 5-HT1A receptors. Docking studies clearly show that hexyl and ethyl compounds favourably interact with the binding site of the active conformation of 5-HT1A receptors, thus confirming a possible agonist profile. This activity is effectively detected in electrophysiological experiments in which all four compounds inhibit the activity of rat dorsal raphe serotonergic neurons.
Département de pharmacie / Chimie pharmaceutique ; Giga-Neurosciences / Pharmacologie
Fonds de la Recherche Scientifique-FNRS (F.R.S.-FNRS) ; Fonds Spéciaux pour la Recherche de l'Université de Liège